Inventor profile of:

Shimon SLAVIN

City:

Jerusalem

Country:

Israel

Published Applications:

12

Last publication date:

2017-10-26

Top Assignees for applications by Shimon SLAVIN

The entities that hold a legal rights for patent applications filed by inventor SLAVIN Shimon:

Recent patent applications by SLAVIN Shimon

Shimon SLAVIN from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-10-26
US20170305836A1
Chemistry; metallurgy

TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME

#2 | 2014-05-22
US20140142068A1
Chemistry; metallurgy

Telomerase activating compounds and methods of use thereof

#3 | 2014-05-22
US20140142067A1
Chemistry; metallurgy

Telomerase activating compounds and methods of use thereof

#4 | 2014-04-17
US20140107336A1
Chemistry; metallurgy

Tri-aryl compounds and compositions comprising the same

#5 | 2010-10-21
US20100267667A1
Chemistry; metallurgy

Telomerase activating compounds and methods of use thereof

#6 | 2010-10-07
US20100256382A1
Chemistry; metallurgy

Tri-aryl compounds and compositions comprising the same

#7 | 2010-06-24
US20100158973A1
Human necessities

THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS

#8 | 2008-09-04
US20080213332A1
Chemistry; metallurgy

Cells Isolated from Placenta, Device for Isolating Same, and Uses Thereof

#9 | 2007-11-15
US20070264240A1
Human necessities

Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation

#10 | 2007-05-03
US20070099987A1
Human necessities

Treating or preventing diabetes with cannabidiol

#11 | 2006-08-10
US20060177387A1
Human necessities

Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formation

#12 | 2006-06-01
US20060115481A1
Chemistry; metallurgy

Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy

InventorID:

729178 ⎘